Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2025-12-31 @ 6:21 PM
Study NCT ID:
NCT07225361
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Sponsor:
Northwestern University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2029-03-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-29
First Submit QC Date:
None
Study First Post Date:
2025-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL